Collaborative Stage

Note 1: The International Prognostic Index (IPI) has been developed for lymphomas and predicts outcome based on the following adverse factors:
    Age greater than or equal to 60 years
    Ann Arbor Stage III or IV
    More than 1 extranodal site involved
    Patient's performance status (Eastern Cooperative Oncology Group, ECOG) 2, 3, or 4
    Elevated serum lactate dehydrogenase (LDH) level
Note 2: Record the IPI as stated in the medical record. Do not calculate points or assign risk. Only record points or risk if a physician has documented them. Use points over risk if both are available.
Note 3: There are now three indices/scores associated with lymphoma: The International Prognostic Index (IPI, CS Site-Specific Factor 3), the Follicular Lymphoma International Prognostic Index (FLIPI, CS Site-Specific Factor 4), and the International Prognostic Score (IPS) (for Hodgkin lymphomas, CS Site-Specific Factor 5).   Physicians may use these indices/scores interchangeably. For coding:
    Score identified: Value in appropriate CS SSF, 999 in other two CS SSF
    Score not identified, point value 5 or less: 999 in all three CS SSF
    Score not identified, point value 6 or 7: Value in CS SSF 5 (IPS), 999 in other two CS SSF.

Code	Description
000	0 points
001	1 point
002	2 points
003	3 points
004	4 points
005	5 points
988	Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code 988 will result in an edit error.)
990	Stated as low risk (0-1 point)
991	Stated as low intermediate risk (2 points)
992	Stated as intermediate risk (3 points)
993	Stated as high risk (4-5 points)
999	Unknown or no information Not documented in patient record

CS Site-Specific Factor 3International Prognostic Index (IPI)